ATE265221T1 - Modifizierte, verkürzte regulatoren des komplementsystems - Google Patents

Modifizierte, verkürzte regulatoren des komplementsystems

Info

Publication number
ATE265221T1
ATE265221T1 AT94929330T AT94929330T ATE265221T1 AT E265221 T1 ATE265221 T1 AT E265221T1 AT 94929330 T AT94929330 T AT 94929330T AT 94929330 T AT94929330 T AT 94929330T AT E265221 T1 ATE265221 T1 AT E265221T1
Authority
AT
Austria
Prior art keywords
regulators
proteins
shortened
modified
complement system
Prior art date
Application number
AT94929330T
Other languages
English (en)
Inventor
John P Atkinson
Dennis Hourcade
Malgorzata Krych
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/126,505 external-priority patent/US6897290B1/en
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE265221T1 publication Critical patent/ATE265221T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Inorganic Insulating Materials (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Amplifiers (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94929330T 1993-09-24 1994-09-23 Modifizierte, verkürzte regulatoren des komplementsystems ATE265221T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/126,505 US6897290B1 (en) 1991-05-03 1993-09-24 Modified RCA proteins
PCT/US1994/010820 WO1995008343A1 (en) 1993-09-24 1994-09-23 Modified truncated complement system regulators

Publications (1)

Publication Number Publication Date
ATE265221T1 true ATE265221T1 (de) 2004-05-15

Family

ID=22425192

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94929330T ATE265221T1 (de) 1993-09-24 1994-09-23 Modifizierte, verkürzte regulatoren des komplementsystems

Country Status (7)

Country Link
EP (1) EP0730469B1 (de)
JP (1) JPH09506764A (de)
AT (1) ATE265221T1 (de)
AU (1) AU691525B2 (de)
CA (1) CA2171953C (de)
DE (1) DE69433745T2 (de)
WO (1) WO1995008343A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU733249B2 (en) * 1996-08-09 2001-05-10 Stichting Sanquin Bloedvoorziening Methods and means for modifying complement activation
GB9704519D0 (en) 1997-03-05 1997-04-23 Smithkline Beecham Plc Compounds
GB9706950D0 (en) * 1997-04-05 1997-05-21 Chernajovsky Yuti Immune modulation by polypeptides related to CR1
WO2000061752A2 (en) * 1999-04-09 2000-10-19 Washington University Modified complement system regulators
CA2857168C (en) * 2011-12-01 2020-10-27 Protevobio, Inc. Protein inhibitors to complement and vegf pathways and methods of use thereof
CA2877441A1 (en) 2012-07-02 2014-01-09 Medizinische Universitat Wien Complement split product c4d for the treatment of inflammatory conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212071A (en) * 1988-04-01 1993-05-18 The Johns Hopkins University Nucleic acids encoding a human C3b/C4b receptor (CR1)
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤
EP0512733A2 (de) * 1991-05-03 1992-11-11 Washington University Modifizierter Komplementsystemregler

Also Published As

Publication number Publication date
EP0730469A1 (de) 1996-09-11
WO1995008343A1 (en) 1995-03-30
AU691525B2 (en) 1998-05-21
DE69433745D1 (de) 2004-06-03
AU7842494A (en) 1995-04-10
EP0730469A4 (de) 1999-03-31
JPH09506764A (ja) 1997-07-08
CA2171953A1 (en) 1995-03-30
EP0730469B1 (de) 2004-04-28
DE69433745T2 (de) 2005-05-19
CA2171953C (en) 2003-02-04

Similar Documents

Publication Publication Date Title
CA2067653A1 (en) Modified Complement System Regulator
DE69331758D1 (de) Fibrinogen-bildungsprotein
DK0797666T3 (da) Genetisk manipulerede humane Kunitz-domæner, der inhiberer human neutrofil elastase
ATE380875T1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
DE68927379D1 (de) Plättchen blockierende peptide
DK0601154T3 (da) BPC-peptider, deres fremstilling og anvendelse
ATE205857T1 (de) Grosse, latente komplexe von tgf-beta2 und tgf- beta3
FI961044A7 (fi) Kininogeeni-inhibiittorit
DE69334146D1 (de) Peptide mit gdp-austauschfaktorartiger wirkung, dafür kodierende nukleinsäuresequenzen, ihre herstellung und verwendung
DE69433400D1 (de) Neue proteine von parasitischen würmern
DE68917837D1 (de) Peptid-Verbindungen.
DE69433745D1 (de) Modifizierte, verkürzte regulatoren des komplementsystems
DK403384D0 (da) Enteralt effektivt, biologisk aktivt peptid- eller proteinmiddel ogfremgangsmaader til fremstilling deraf
ATE196926T1 (de) Gen grb3-3, variante und ihre verwendungen
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
DE69432427D1 (de) Tomate xyloglukan endotransglykosylase
DE69032574D1 (de) Antibakterielle- und antimalariapeptide
RU95107705A (ru) Полипептид, рекомбинантный полинуклеотид, вакцина, применение вакцины
DK210088A (da) Fremgangsmaade til selektiv spaltning af peptidbindinger, isaer med henblik paa bestemmelse af aminosyresekvenser
DE69122103D1 (de) Antigerinnungspeptide
ATE276272T1 (de) Entzündungshemmende peptide
ES511760A0 (es) Procedimiento para eliminar el grupo n-formilo de peptidos n-formilo de peptidos n-formilados o de esteres de peptidos n-formilados.
NO891320D0 (no) Selektiv foroekning av maalpolynuklotidsekvenser.
ES345979A1 (es) Procedimiento para la preparacion de un agente proteinico anti-inmunitario.
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties